Olema Oncology Secures $218.5 Million from Oversubscribed Public Offering—What Does This Mean for Their Breast Cancer Drug Pipeline?
Market Chameleon (Fri, 21-Nov 8:34 AM)
Olema Oncology Raises $190 Million in Public Offering—What Could This Mean for the Company’s Clinical Pipeline?
Market Chameleon (Thu, 20-Nov 10:33 AM)
Olema Oncology Unveils Public Offering of Common Stock and Pre-Funded Warrants—What Does This Mean for Investors?
Market Chameleon (Wed, 19-Nov 10:30 AM)
Olema Oncology Raises $190 Million in Oversubscribed Stock Offering—What Could This Mean for Its Breast Cancer Pipeline?
Market Chameleon (Wed, 19-Nov 7:07 AM)
